Trial Profile
Outcomes and Computed Tomography Scan Follow-Up of Bioresorbable Vascular Scaffold for the Percutaneous Treatment of Chronic Total Coronary Artery Occlusion.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Nov 2015
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Coronary arteriosclerosis
- Focus Therapeutic Use
- 13 Nov 2015 New trial record